Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT04305405
Status:
COMPLETED
Last Update Posted:
2023-05-18
First Post:
2019-11-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-15
First Submit QC Date:
None
Study First Post Date:
2020-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-04-06
Results First Submit QC Date:
None
Results First Post Date:
2023-05-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-16
Last Update Post Date:
2023-05-18
Last Update Post Date Type:
ACTUAL